Home › Compare › EMMLF vs EQR

EMMLF vs EQR: Dividend Comparison 2026

EMMLF yields 14598.54% · EQR yields 5.87%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 EMMLF wins by $2315127447129181184.00M in total portfolio value
10 years
EMMLF
EMMLF
● Live price
14598.54%
Share price
$0.01
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$2315127447129181184.00M
Annual income
$2,284,345,916,069,374,600,000,000.00
Full EMMLF calculator →
EQR
EQR
● Live price
5.87%
Share price
$59.15
Annual div
$3.47
5Y div CAGR
15.8%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$47.8K
Annual income
$5,475.61
Full EQR calculator →

Portfolio growth — EMMLF vs EQR

📍 EMMLF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodEMMLFEQR
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, EMMLF + EQR cover 0 of 12 months — good coverage

Jan
—
Feb
—
Mar
—
Apr
—
May
—
Jun
—
Jul
—
Aug
—
Sep
—
Oct
—
Nov
—
Dec
—
EMMLF pays
EQR pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

EMMLF
Annual income on $10K today (after 15% tax)
$1,240,875.91/yr
After 10yr DRIP, annual income (after tax)
$1,941,694,028,658,968,500,000,000.00/yr
EQR
Annual income on $10K today (after 15% tax)
$499.01/yr
After 10yr DRIP, annual income (after tax)
$4,654.27/yr
At 15% tax rate, EMMLF beats the other by $1,941,694,028,658,968,500,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of EMMLF + EQR for your $10,000?

EMMLF: 50%EQR: 50%
100% EQR50/50100% EMMLF
Portfolio after 10yr
$1157563723564590592.00M
Annual income
$1,142,172,958,034,687,300,000,000.00/yr
Blended yield
98.67%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

EMMLF
No analyst data
EQR
Analyst Ratings
16
Buy
28
Hold
2
Sell
Consensus: Hold
Price Target
$70.35
+18.9% upside vs current
Range: $63.00 — $78.50
Altman Z
1.8
Piotroski
7/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

EMMLF buys
0
EQR buys
0
No recent congressional trades found for EMMLF or EQR in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricEMMLFEQR
Forward yield14598.54% ✓5.87%
Annual dividend / share$2.00$3.47 ✓
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%15.8% ✓
Portfolio after 10y$2315127447129181184.00M ✓$47.8K
Annual income after 10y$2,284,345,916,069,374,600,000,000.00 ✓$5,475.61
Total dividends collected$2313090038871241728.00M ✓$23.0K
Payment frequencyquarterlyquarterly
SectorStockREIT

Year-by-year: EMMLF vs EQR ($10,000, DRIP)

YearEMMLF PortfolioEMMLF Income/yrEQR PortfolioEQR Income/yrGap
1← crossover$1,470,554$1,459,854.01$11,380$679.82+$1.46M → EMMLF
2$202,208,463$200,634,970.27$13,014$837.25+$202.20M → EMMLF
3$25,999,823,322$25,783,460,266.67$14,961$1,036.20+$25999.81M → EMMLF
4$3,126,155,661,671$3,098,335,850,716.16$17,297$1,289.22+$3126155.64M → EMMLF
5$351,509,831,288,492$348,164,844,730,504.60$20,121$1,613.15+$351509831.27M → EMMLF
6$36,963,217,951,789,784$36,587,102,432,311,096.00$23,561$2,030.84+$36963217951.77M → EMMLF
7$3,635,193,394,947,107,000$3,595,642,751,738,691,600.00$27,783$2,573.54+$3635193394947.08M → EMMLF
8$334,373,707,794,473,750,000$330,484,050,861,880,400,000.00$33,013$3,284.39+$334373707794473.69M → EMMLF
9$28,767,786,037,201,900,000,000$28,410,006,169,861,807,000,000.00$39,547$4,223.51+$28767786037201900.00M → EMMLF
10$2,315,127,447,129,181,000,000,000$2,284,345,916,069,374,600,000,000.00$47,791$5,475.61+$2315127447129181184.00M → EMMLF

EMMLF vs EQR: Complete Analysis 2026

EMMLF — Stock

OKYO Pharma Limited, a preclinical biopharmaceutical company, engages in developing therapeutics for patients suffering from inflammatory eye diseases and ocular pain in the United Kingdom. Its lead product includes OK-101 for the treatment of dry eye disease. The company is also developing OK-201, a bovine adrenal medulla, lipidated-peptide preclinical analogue candidate for the treatment of neuropathic ocular pain. OKYO Pharma Limited was incorporated in 2007 and is headquartered in London, the United Kingdom.

Full EMMLF Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →
📬

Get this EMMLF vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

EMMLF vs SCHDEMMLF vs JEPIEMMLF vs OEMMLF vs KOEMMLF vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.